ライフサイエンスコーパス: -positive

1 elatively few PD-1+ (programmed cell death 1-positive) T cells, an immunophenotypic pattern also obse

2 (68)Ga-PSMA-11-positive lesions not covered by planning volumes based o

3 Of note, Optn was recruited to Atg12-5-16L1-positive puncta, and interacted with Atg5 and also with

4 We also found that the number of Atg12/16L1-positive puncta and recruitment of the Atg12-5-16L1 comp

5 MATERIAL AND IL-22- and IL-17-positive T cells were sorted from human peripheral blood

6 the DDC-stimulated number of cytokeratin-19-positive cells in the liver of wild-type animals was sli

7 for human epidermal growth factor receptor 2-positive (luminal and nonluminal) tumors (15% v 19%; P =

8 ve, human epidermal growth factor receptor 2-positive early-stage breast cancer.

9 ctivity retained in the postnatal 20alphaHSD-positive postnatal X-zone cells.

10 hyaline, TAR DNA-binding protein 43 (TDP-43)-positive inclusions.

11 l tissues from anti-citrullinated protein Ab-positive arthralgia, undifferentiated arthritis (UA), ea

12 The prevalence of THSD7A-Ab-positive patients is unknown, and it is unclear whether

13 sizes for group differences (Cohen d; Abeta-positive impaired vs. Abeta-negative normal) were evalua

14 d CD19(-) relapses in patients with BCR-ABL1-positive ALL.

15 tute the basis for a new mouse model of ACPA-positive RA.

16 ositive cells, and alpha-smooth muscle actin-positive blood vessels were assayed at postoperative day

17 ll migration, tumorsphere formation and ALDH-positive cancer stem cell population, in vitro.

18 GA1 signaling promotes the survival of ALDH1-positive stem-like cells and cooperates with TGFbeta to

19 4 patients with metastatic or inoperable ALK-positive IMT received crizotinib orally twice daily.

20 dy, 26 patients with relapsed/refractory ALK-positive ALCL and 14 patients with metastatic or inopera

21 latelet-derived growth factor receptor-alpha-positive cells, and alpha-smooth muscle actin-positive b

22 The mortality of AMA-positive patients without PBC is increased irrespective

23 AMR-positive patients had more dnDSA with a significant high

24 volume (both including and excluding amyloid-positive participants), group differences in amyloid upt

25 agement of hepatitis B virus (HBV) e antigen-positive viremic patients with normal liver function and

26 ignificant decrease in THP-, NKCC2- and AQP1-positive loop of Henle nephron segments in mutant DeltaS

27 The optimal cutoff for AR-positive lesions was an SUVmax of 1.94 for (18)F-FDHT PE

28 AR and suppresses the growth of multiple AR-positive, but not AR-negative, prostate cancer cells.

29 this cytokine is uniformly absent in the AR-positive (AR+) metastatic cells.

30 with newly diagnosed T1D and in autoantibody-positive at-risk children with impaired glucose toleranc

31 eriostin and transforming growth factor beta-positive cells within Asm bundles, in addition to lower

32 describe 1) the use of enrichment (biomarker-positive patients) and a randomized controlled design by

33 linical studies were restricted to biomarker-positive patients (enriched).

34 Modeling C1q status showed that C1q-positive patients had significantly higher mean eGFR tha

35 Five of 8 C4d-positive recipients turned C4d-negative in 5-week follow

36 y, and tract-tracing analysis revealed Cadm1-positive innervation of POMC neurons via afferent projec

37 d protein levels in cells infected with cagA-positive infections compared to cells infected with eith

38 on in Parkinson's disease, and the calbindin-positive dorsal tier, which is relatively resilient.

39 Thus, calbindin-positive and calbindin-negative SNc neurons differ subst

40 MR) and 1 partial molecular response in CALR-positive ruxolitinib-treated patients.

41 ell lines, discriminating between the cancer-positive and -negative cells, without any amplification

42 16 Fc-receptor profiles were compared in CAV-positive (n=52) and CAV-free patients (n=51).

43 tive T cells to recognize and eliminate CD19-positive acute lymphoblastic leukemia (ALL) blasts, was

44 The CD20-positive cells did not display the typical B cell morpho

45 ically confirmed, previously untreated, CD20-positive grade 1, 2, or 3a follicular lymphoma; Eastern

46 dy, adults with relapsed or refractory, CD22-positive, Philadelphia chromosome (Ph)-positive or Ph-ne

47 ng hypertrophic-like scars, whereas few CD26-positive cells were present in the regenerated gingival

48 During skin wound healing, CD26-positive cells accumulated over time and persisted in fo

49 a conventional MMAE warhead destroyed CD276-positive cancer cells, but were ineffective against tumo

50 noclonal antibody construct that enables CD3-positive T cells to recognize and eliminate CD19-positiv

51 , reduced neuronal density, perivascular CD3-positive T-lymphocyte clustering, and fibrinogen extrava

52 trial, we enrolled adult patients with CD30-positive mycosis fungoides or primary cutaneous anaplast

53 DT endothelium was Prox1-positive, CD31-positive and LYVE-1-negative, bearing a different molecu

54 ded to engage and render gluten-specific CD4-positive T cells unresponsive to further antigenic stimu

55 unodominant epitopes for gluten-specific CD4-positive T cells.

56 However, CGRP-positive nerves were significantly more superficial in m

57 The distribution of CGRP-positive nerves did not differ significantly between the

58 er having been contact-traced by a chlamydia-positive partner were more likely to have CVM dominated

59 lockade can suppress Philadelphia chromosome-positive leukemia in mice, suggesting that this therapeu

60 les, in addition to lower numbers of chymase-positive mast cells in the submucosa compared to patient

61 eriments indicated that the majority of COL1-positive fibroblasts stem from a pool of SOX9-expressing

62 H in spheroidal tissue growths of connexin43-positive pancreatic cancer Colo357 cells during light-co

63 lotus tetragonolobus lectin-negative/p-Creb-positive cyst segments (re)-expressed Ncam1, Pax2, and S

64 ility to differentiate into gamma-crystallin-positive lentoids by high-dosage bFGF treatment.

65 ta available expectorated infectious culture-positive cough aerosols in the respirable range (<5 mum)

66 with presumptive PTB, 20 (6.3%) were culture-positive for Mycobacterium tuberculosis.

67 The proportions of participants with culture-positive PTB initiated on appropriate TB treatment withi

68 to rigid substrates with Gaussian curvature-positive for spheres and negative for saddles-has proven

69 By immunohistochemistry, the number of CXCR3-positive mononuclear cells was higher in skin and intest

70 y confirmed cases and chest radiograph (CXR)-positive cases compared to controls.

71 n-1-yl)benzenesulfonates (PIB-SOs) in CYP1A1-positive cancer cells, both in vitro and in vivo.

72 Of these, 92% tested D816V-positive in the screening blood sample.

73 PCs were further differentiated into DARPP32-positive neurons, these HD neurons were more susceptible

74 peptide can decrease aldehyde dehydrogenase-positive BCSCs and mammosphere formation capacity in SUM

75 s generated interest in the use of these DIC-positive grafts.

76 f high-affinity signaled CD4(+)CD8(+) double-positive thymocytes and CD8(+) and CD4(+) single-positiv

77 ve selection of immature CD4(+)CD8(+) double-positive thymocytes and their commitment to the CD4(+)CD

78 is protein expression is increased in double-positive thymocytes undergoing positive selection and is

79 elective targeting and eradication of double-positive human NCI-H358 non-small cell lung cancer targe

80 imilar with respect to the numbers of double-positive thymocytes, CD4(+)CD8(-) T cells, regulatory T

81 that they modulate the excitability of DRD1-positive MSNs in nAc.

82 ing features and mutation status (e.g., EGFR-positive [EGFR+] vs. EGFR-negative) was assessed using t

83 kin-6 (IL-6) cytokine secreted from EGFRvIII-positive tumor cells.

84 Greater than 50% of estrogen receptor (ER)-positive breast cancers coexpress the progesterone recep

85 WAS) of predominantly estrogen receptor (ER)-positive disease.

86 or, is currently in phase III studies for ER-positive breast cancer and KRAS mutant lung cancer.

87 neity by localizing immunohistochemically ER-positive metastases that lack receptor-binding functiona

88 sal ErbB2 receptor tyrosine kinase 2 (ErbB2)-positive breast cancer (ErbB2(KI)), which exhibits aberr

89 of patients will be diagnosed with an ErbB2-positive tumor.

90 ng clusters of risk TFs associated with ESR1-positive and -negative breast cancer can physically inte

91 f both interferon- and tumor necrosis factor-positive CD4(+) T cells and CD8(+) T cells.

92 of leukocytes, platelets, and tissue factor-positive (TF(+)) microvesicles (MVs) are all potential f

93 ale, CA) found no false-negative and 4 false-positive cobas Cdiff test results.

94 ; 95% CI 88.4-100) with two additional false-positive results (specificity 99.9%; 99.7-100).

95 nts incorrectly treated with ART after false-positive diagnosis (e.g., medication toxicities); includ

96 hnical parameters, number of true- and false-positive and true- and false-negative results were extra

97 positive predictive values (PPVs) and false-positive rates, with a lack of precision in accuracy est

98 itively correlates with the behavioral false-positive rate of face choices.

99 ng amounts of CCDs sufficient to cause false-positive test results up to 2 kUA/L with nonglycosylated

100 indicated by the false-negative (FN), false-positive (FP), and fixation loss (FL) rates, on global i

101 ies, or other procedures performed for false-positive or indeterminate surveillance results.

102 MELD exceptions, of which 245 (6%) had false-positive HCC.

103 ponses but are not more likely to have false-positive DSE results.

104 tential harms of treatment (ie, higher false-positive rates in low-prevalence populations) as small.

105 Importantly, false-positive rates were not affected by selection bias.

106 e this approach to show a reduction in false-positive peaks as well as improved consistency across la

107 150 (95% CI, 146-154) had one or more false-positive tests equating to a number needed to harm from

108 ects with F0-F2 fibrosis, the rates of false-positive LSM results for F3-F4 fibrosis increased accord

109 genetic dependency, thereby leading to false-positive results in copy number-amplified regions.

110 for gelatin, problems associated with false-positive and false-negative results, inconsistencies and

111 tcomes included number of infants with false-positive diagnoses linked to ART per 1,000 ART initiatio

112 In comparison to spoligotyping of acid-fast-positive MGIT cultures, percent agreement between positi

113 ion-free survival in patients with EGFR FISH-positive cancer and overall survival in the entire study

114 subgroup analyses of patients with EGFR FISH-positive squamous-cell carcinoma cancers are encouraging

115 tients with advanced NSCLC who are EGFR FISH-positive.

116 4 expression in a small subpopulation of FOS-positive neurons in the NAc.

117 numbers of antigen-specific CD8(+) IFN-gamma-positive cells following injection into BALB/c mice.

118 FNgamma drives recruitment of TRIM21 to GBP1-positive Toxoplasma vacuoles, leading to Lys63-linked ub

119 Among the GCA-positive group, 3 patients had positive staining for her

120 rtunities for targeted therapy to treat GDF6-positive cancers.

121 p testing, all glutamate dehydrogenase (GDH)-positive specimens, regardless of fecal toxin result, fr

122 cohort studies in the literature, 8% of gene-positive patients were published to have double mutation

123 ated by nude mice bearing subcutaneous GPA33-positive SW1222 xenografts.

124 gulator Spx is ubiquitously found among Gram-positive bacteria.

125 in family, which is spread widely among gram-positive bacteria; and suggests approaches to target RRN

126 , uncultivable asaccharolytic anaerobic Gram-positive rods and other uncultivable Gram-negative rods,

127 rains, including both Gram-negative and Gram-positive bacteria, showing great potential for applicati

128 etion systems in many Gram-negative and Gram-positive bacteria.

129 successfully monitor the growth of both gram-positive (Staphylococcus aureus and Streptococcus pyogen

130 formation of competence-induced pili in Gram-positive bacteria and corroborate the remarkable structu

131 ever, the mechanisms of MV formation in Gram-positive bacteria are unclear, as these cells possess a

132 target for evaluating antimicrobials in gram-positive bacteria.

133 pore-forming proteins secreted by many Gram-positive bacterial pathogens.

134 For many gram-positive pathogens, conjugative plasmid transfer is an i

135 tibacterial activity against a panel of Gram-positive and Gram-negative bacteria revealed structure-a

136 dae can infect commensal and pathogenic Gram-positive and Gram-negative bacteria.

137 nolamine halve during elongation of the Gram-positive bacterium Listeria innocua.

138 dnaK mutants, rather than those in the Gram-positive model organism Bacillus subtilis.

139 The Gram-positive pathogen Staphylococcus aureus uses one primary

140 e is a better predictor of HD and HCC in HCV-positive persons.

141 proves outcome in patients with ERBB2 (HER2)-positive metastatic breast cancer; a clinically effectiv

142 Conclusion The ADAPT HER2-positive/HR-positive trial demonstrates that neoadjuvant

143 ities of TILs in patients with advanced HER2-positive breast cancer treated with either pertuzumab or

144 Patients were classified as HER2-positive (HER2+) or -negative (HER2-) based on fluoresce

145 d >/=18 years) with centrally confirmed HER2-positive advanced breast cancer previously treated with

146 DM1 versus trastuzumab with ET in early HER2-positive/HR-positive breast cancer.

147 B2/HER2-negative BrCa switched to ERBB2/HER2-positive with 1 BrM acquiring ERBB2/HER2 amplification a

148 avidity was a true-positive result for HER2-positive malignancy.

149 Eligible patients had HER2-positive advanced gastric cancer and progressed during o

150 NHERF1 expression is increased in HER2-positive breast cancers and correlates with HER2-positiv

151 butes to an enhanced HER2 expression in HER2-positive breast cancers with HER2 gene amplification and

152 report evaluating (89)Zr-trastuzumab in HER2-positive EGA; here, we evaluate the safety, pharmacokine

153 egative tumors, 82.8% of luminal B-like HER2-positive tumors, 21.3% of HER2-enriched tumors, and 7.8%

154 ard of care for first-line treatment of HER2-positive advanced gastric cancer, there is no establishe

155 resection of a brain metastasis proved HER2-positive disease, confirming that the (89)Zr-pertuzumab

156 ent of patients with previously treated HER2-positive advanced breast cancer, and validate HER2 as a

157 RBB2)-targeted therapy in patients with HER2-positive breast cancer.

158 placebo-controlled trial, patients with HER2-positive early breast cancer were randomly assigned to r

159 ated for the treatment of patients with HER2-positive metastatic breast cancer previously treated wit

160 prediction of outcomes in patients with HER2-positive metastatic breast cancer randomized to an antib

161 imaging of the brain for patients with HER2-positive or triple-negative subtypes and extracranial me

162 tive breast cancers and correlates with HER2-positive status in human ductal carcinoma in situ (DCIS)

163 performed on murine xenografts of U87MG (HGF-positive, MET-positive) and MKN45 (HGF-negative, MET-pos

164 Of 6,197 HIV-positive adults referred by CHiPs, 42% (95% CI: 40%-43%)

165 els in CSF and plasma specimens from 220 HIV-positive adults who were taking suppressive ART.

166 ately half of 40 tumor specimens from 23 HIV-positive and 17 HIV-negative patients (29 men and 11 wom

167 The overall prevalence among HIV-positive women was 1.3% (95% CI 0.8-1.9) for tobacco smo

168 However, HIV-positive blacks continue to have much higher rates of ES

169 South Africa, HRQoL scores were lower in HIV-positive individuals who were aware of their status but

170 Deaths in HIV-positive people have decreased since the introduction of

171 with HIV know their status, 90% of known HIV-positive individuals receive sustained antiretroviral th

172 randomised controlled trial in ART-naive HIV-positive patients with CD4 cell count of more than 500 c

173 The life expectancy of HIV-positive individuals receiving antiretroviral therapy (A

174 This target aims for 90% of HIV-positive individuals to be aware of their status, for 90

175 t to the optimal monitoring frequency of HIV-positive individuals.

176 scuss viral load monitoring for pregnant HIV-positive women and those breastfeeding; ART treatments c

177 clusters (58 cluster-years) and referred HIV-positive participants to trial clinics for ART (fixed-do

178 e to have much higher rates of ESRD than HIV-positive whites, which could be attributed to the APOL1

179 years, 62 (78.5%) were unaware of their HIV-positive status, 76 (96.2%) were not on antiretroviral t

180 Patients with human papillomavirus (HPV)-positive head and neck squamous cell carcinoma (HNSCC) h

181 ng patients with human papilloma virus (HPV)-positive tumors.

182 repair, CHK1 and Wee1, are suppressed in HPV-positive cells, providing an explanation for why this mi

183 ion for why this microRNA is targeted in HPV-positive cells.IMPORTANCE We describe here for the first

184 In Africa, HPV 16 accounted for 13% of HPV-positive WHIV with normal cytological findings, but this

185 It is widely assumed that HPV-positive cancer cells are under selection pressure to co

186 tively poor prognosis in comparison with HPV-positive disease, with decreased locoregional control an

187 rastuzumab with ET in early HER2-positive/HR-positive breast cancer.

188 Conclusion The ADAPT HER2-positive/HR-positive trial demonstrates that neoadjuvant T-DM1 (with

189 ICD-positive patients had more severe depression, poorer sle

190 n LGI1-IgG-positive (41%) than in CASPR2-IgG-positive patients (p = 0.033).

191 33nmol/l, range = 0.02-5.14) than CASPR2-IgG-positive specimens (0.10nmol/l, range = 0.00-0.45, p < 0

192 l hyperintensity was more common in LGI1-IgG-positive (41%) than in CASPR2-IgG-positive patients (p =

193 LGI1-IgG-positive specimens had higher voltage-gated potassium ch

194 Samoa and Puerto Rico, more than 80% of IgM-positive results were unspecified flavivirus infections.

195 lcium/calmodulin-dependent protein kinase II-positive principal cells as well as of parvalbumin- or s

196 We report recruitment of mannosidase-II-positive Golgi-derived vesicles during uptake of diverse

197 Urinary tract infection-positive burn patients with altered urinary antimicrobia

198 iminate critically ill adults with infection-positive versus infection-negative systemic inflammation

199 sues displayed significantly smaller insulin-positive areas, lower proportion of beta-cells positive

200 CMDR boost, vaccine-induced gamma interferon-positive (IFN-gamma(+)) Gag-specific T-cell responses we

201 ssociates predominantly with a distinct KSR1-positive endosomal population.

202 tic acid (DTPA)-anti-PD-L1-to identify PD-L1-positive tumors in vivo.

203 In vivo studies were performed in PD-L1-positive, PD-L1-negative, and mixed tumor-bearing severe

204 d flux but has no significant effect on LC3B-positive autophagosome formation.

205 Tumors were called MCPyV-positive if two or more of these three assays indicated

206 oup (ECOG) performance status of 0 or 1, MET-positive tumours (>/=25% of tumour cells with membrane s

207 , MET-positive) and MKN45 (HGF-negative, MET-positive) and 4 patient-derived xenografts (MET-positive

208 urine xenografts of U87MG (HGF-positive, MET-positive) and MKN45 (HGF-negative, MET-positive) and 4 p

209 itive) and 4 patient-derived xenografts (MET-positive, HGF unknown).

210 Of 23 microscopy-positive participants, 22 were positive by serology (95.

211 e POC-CCA testing detected all 23 microscopy-positive study participants (100% sensitivity).

212 The Mitf-positive melanoblasts were not restricted to the dorsola

213 FC showed similar 5-year EFS and OS for MRD-positive and -negative patients using an MRD threshold o

214 1.3% of the environmental isolates were MRSA-positive.

215 argetable antioxidant enzyme in APC-mutation-positive colorectal cancer.2-Cys peroxiredoxin (Prx) enz

216 promoter methylation levels in CDH1 mutation-positive families, including penetrants, non-penetrants

217 approximately 0.8% of unrelated NF1 mutation-positive probands in the University of Alabama at Birmin

218 MTBDRplus was performed on mycobacteria-positive cultures to ascertain acquired drug resistance

219 Nanoparticle-positive areas further exhibited impaired endothelial ba

220 rum compounds transcending the Gram negative-positive borderline.

221 a high ratio of podocin-positive to nephrin-positive urinary EVs (podocin(+) EVs-to-nephrin(+) EVs r

222 sion criteria (7,906 N0 patients; 6,648 node-positive patients).

223 In node-positive breast cancer patients treated with neoadjuvant

224 rmone receptor-positive, HER2-negative, node-positive breast cancer, the MammaPrint assay may be used

225 t trastuzumab for adjuvant treatment of node-positive, human epidermal growth factor receptor 2-posit

226 Women with node-positive breast cancer are at high risk for recurrence.

227 basal forebrain neurons were also p75(NTR) -positive.

228 pithelial nerve regeneration and substance P-positive nerve density in both wounded and unwounded eye

229 PCM1 enhances GABARAP/WIPI2/p62-positive autophagosome formation and flux but has no sig

230 The maturation of cortical parvalbumin-positive (PV) interneurons depends on the interaction of

231 ally activating somatostatin- or parvalbumin-positive interneurons, even transiently during the delay

232 ortex, particularly fast-spiking parvalbumin-positive (PV+) basket cells.

233 The distribution of load among PCR-positive participants was compared between microbiologic

234 patients with clinically diagnosed ARN, PCR-positive for herpes simplex virus or varicella zoster vi

235 PET-positive LNs had significantly higher CT densities than

236 range, 0.25-294 ng/mL), 362 (68)Ga-PSMA PET-positive lymph nodes (LNs) were identified.

237 stem cell transplantation (ASCT) whereas PET-positive patients received augICE before ASCT.

238 bility to stimulate, and the complemented PF-positive T. denticola strain restored the activation.

239 CD22-positive, Philadelphia chromosome (Ph)-positive or Ph-negative B-cell acute lymphoblastic leuka

240 t shares significant overlap with that of Ph-positive (Ph(+)) ALL and is suggestive of activated kina

241 Patients were classified as phenotype-positive (n=72) or phenotype-negative (n=102).

242 elevated tartrate-resistant acid phosphatase-positive (TRAP+) OCs and alveolar bone loss.

243 regnancies contained a high ratio of podocin-positive to nephrin-positive urinary EVs (podocin(+) EVs

244 Polyomavirus-positive patients (n = 943) were defined as having any o

245 DT endothelium was Prox1-positive, CD31-positive and LYVE-1-negative, bearing a d

246 arance kinetics but identical uptake in PSMA-positive tissues in the LNCaP xenograft model (1 h after

247 iling view is that striatal parvalbumin (PV)-positive interneurons primarily function to downregulate

248 nalization, GPRC6A is recycled via the Rab11-positive slow recycling pathway, which may be responsibl

249 mas, but it is not clear which additional Rb-positive cancers might benefit from these agents.

250 Furthermore, intact G1/S transition (Rb-positive and low-molecular-weight isoform of cyclin E (c

251 for those living in the household of an RDT-positive individual and 1.64 (1.0-2.8; P = .06) for thos

252 From 1353 patients, 93.0% of RDT-positive (n = 185) and 31.2% of RDT-negative samples (n

253 led to sustained expansion of IL-33 receptor-positive kidney ILC2s and ameliorated adriamycin-induced

254 Thus, B1 receptor-positive endothelial microvesicles may contribute to chr

255 mC, 0.55), but mainly for estrogen receptor-positive disease (IQ-OR, 1.44; 95% CI, 1.16 to 1.79; P f

256 uded endocrine-refractory, estrogen receptor-positive metastatic breast cancer.

257 ent-derived xenograft, the estrogen receptor-positive model T126, was chosen to generate in vivo mous

258 mor to avoid reexcision in estrogen receptor-positive progesterone receptor-positive cancer and 63% f

259 treatment in patients with hormone receptor-positive advanced breast cancer who were not given dexam

260 ostmenopausal patients with hormone receptor-positive early breast cancer.

261 to hormone receptor status (hormone receptor-positive vs hormone receptor-negative), nodal status (0

262 ically confirmed metastatic hormone receptor-positive, HER2-negative breast cancer.

263 If a patient has hormone receptor-positive, HER2-negative, node-positive breast cancer, th

264 In hormone receptor-positive/HER2-negative (n = 318) disease, BCSS was 100%

265 or cytologically confirmed hormone-receptor-positive, HER2-negative, locally advanced or metastatic

266 ogen receptor-positive progesterone receptor-positive cancer and 63% for estrogen receptor-negative p

267 ing approach where mRNA from PGE2-G response-positive and -negative cell lines was subjected to trans

268 er, cocaine increased DAT exit from retromer-positive endosomes significantly.

269 lammatory cytokine secretion from other ROCK-positive cell types, corroborating the selective in vivo

270 CagA with CagA multimerization (CM) sequence-positive H. pylori.

271 Additionally, CyP40 ameliorated silver-positive and oligomeric tau species in a mouse model of

272 tive thymocytes and CD8(+) and CD4(+) single-positive thymocytes.

273 ting protein 2 is not involved in CD8 single-positive thymocyte selection or ERK signaling.

274 he CD45RA(+) mature CD4(+) and CD8(+) single-positive (SP) T cells.

275 ly abolished the generation of CD8(+) single-positive thymocytes.

276 their commitment to the CD4(+)CD8(-) single-positive stage are impaired in Themis(-/-) mice, suggest

277 election and is sustained in immature single-positive thymocytes, despite the strong decrease in Them

278 l cell lung cancer target tumors over single-positive, non-target NCI-H358-HER2 CRISPR knock out tumo

279 ion of alpha-smooth muscle actin (alpha-SMA)-positive myofibroblasts that produced ECM proteins, incl

280 35 (20%) home-discharged cases were smear-positive at discharge.

281 We focused on somatostatin-positive (SST(+)) GABAergic interneurons because of evid

282 s as well as of parvalbumin- or somatostatin-positive interneurons to study the effects of such repet

283 An SRK-positive Bacterial Artificial Chromosome clone was found

284 umor uptake were quantified using SUVmaxPSMA-positive lesions were detected in 12 of 12 prostate canc

285 hat sits at the intersection of several task-positive networks (eg, central executive network, CEN),

286 By analyzing telomerase-positive cells and their human TERC knockout-derived ALT

287 teen studies reported the proportion of test-positive patients who completed colonoscopy compared wit

288 higher frequencies of MHC class II tetramer-positive CD4(+) T cells in HIV controllers than progress

289 persistent, and specific accumulation in TF-positive BXPC-3 tumors, PET imaging using (89)Zr-Df-ALT-

290 onstrated >300,000 tyrosine hydroxylase (TH)-positive grafted cells per side with normalized striatal

291 method, a CT cutoff of 26.35 detected toxin-positive samples with a sensitivity, specificity, positi

292 en who were contact-traced by C. trachomatis-positive sex partners at the STI outpatient clinic in Am

293 expansion of a polyclonal pool of transgene-positive functional T cells and sustained gene marking i

294 Of 213 true-positive samples that were sequenced, 36.2% showed point

295 hat the (89)Zr-pertuzumab avidity was a true-positive result for HER2-positive malignancy.

296 he (68)Ga-DOTATOC PET/CT was considered true-positive if the positive primary site was confirmed by h

297 Also, US28-positive cells were present within arterial neointima.

298 indexes were increased in symptomatic virus-positive children.

299 uitment of the Atg12-5-16L1 complex to Wipi2-positive puncta are reduced in Optn-deficient cells.

300 (G-CSF) levels in the amniotic fluid of ZIKV-positive pregnant women with neonatal microcephaly.